{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:51:52Z","timestamp":1768704712368,"version":"3.49.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["MH079033"],"award-info":[{"award-number":["MH079033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["MH090964, MH109326"],"award-info":[{"award-number":["MH090964, MH109326"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["MH48514"],"award-info":[{"award-number":["MH48514"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","plefa.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.plefa.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T17:00:22Z","timestamp":1489165222000},"page":"38-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: A pilot study"],"prefix":"10.1016","volume":"119","author":[{"given":"Licinia","family":"Ganan\u00e7a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanga C.","family":"Galfalvy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Oquendo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne","family":"Hezghia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. John","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Elizabeth","family":"Sublette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2017.03.004_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7827(00)00017-5","article-title":"The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina","volume":"40","author":"Lauritzen","year":"2001","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.plefa.2017.03.004_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/07315724.2004.10719371","article-title":"Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties","volume":"23","author":"Benatti","year":"2004","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.plefa.2017.03.004_bib3","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1177\/0148607115595980","article-title":"Functional roles of fatty acids and their effects on human health","volume":"39","author":"Calder","year":"2015","journal-title":"J. Parent. Enter. Nutr."},{"key":"10.1016\/j.plefa.2017.03.004_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.brainres.2014.11.059","article-title":"Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease","volume":"1597","author":"Liu","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.plefa.2017.03.004_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2009.01.004","article-title":"Comparative effects of DHA and EPA on cell function","volume":"122","author":"Gorjao","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.plefa.2017.03.004_bib6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.euroneuro.2015.12.031","article-title":"Effects of omega-3 polyunsaturated fatty acids on human brain morphology and function: what is the evidence?","volume":"26","author":"Bos","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.plefa.2017.03.004_bib7","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3390\/md12052341","article-title":"Omega-3 polyunsaturated fatty acids protect neural progenitor cells against oxidative injury","volume":"12","author":"Liu","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.plefa.2017.03.004_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cbf.3012","article-title":"Omega 3 chronic supplementation attenuates myocardial ischaemia-reperfusion injury through reinforcement of antioxidant defense system in rats","volume":"32","author":"Castillo","year":"2014","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.plefa.2017.03.004_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3892\/or.2013.2806","article-title":"Effect of a specific supplement enriched with n-3 polyunsaturated fatty acids on markers of inflammation, oxidative stress and metabolic status of ear, nose and throat cancer patients","volume":"31","author":"Roca-Rodr\u00edguez","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.plefa.2017.03.004_bib10","doi-asserted-by":"crossref","first-page":"1505S","DOI":"10.1093\/ajcn\/83.6.1505S","article-title":"n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases","volume":"83","author":"Calder","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2017.03.004_bib11","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jnutbio.2011.06.014","article-title":"Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA","volume":"23","author":"Oliver","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.plefa.2017.03.004_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2016.03.003","article-title":"Concentration and ratio of essential fatty acids influences the inflammatory response in lipopolysaccharide challenged mice","author":"Hintze","year":"2016","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"key":"10.1016\/j.plefa.2017.03.004_bib13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/and.12173","article-title":"Protective effects of fish omega-3 fatty acids on doxorubicin-induced testicular apoptosis and oxidative damage in rats","volume":"46","author":"Uygur","year":"2014","journal-title":"Andrologia"},{"key":"10.1016\/j.plefa.2017.03.004_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbrc.2015.02.103","article-title":"Omega-3 free fatty acids inhibit tamoxifen-induced cell apoptosis","volume":"459","author":"Wu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2017.03.004_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/nu8040243","article-title":"Long chain Omega-3 polyunsaturated fatty acid supplementation alleviates doxorubicin-induced depressive-like behaviors and neurotoxicity in rats: involvement of oxidative stress and neuroinflammation","volume":"8","author":"Wu","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.plefa.2017.03.004_bib16","doi-asserted-by":"crossref","first-page":"1467S","DOI":"10.1093\/ajcn\/83.6.1467S","article-title":"Distribution, interconversion, and dose response of n-3 fatty acids in humans","volume":"83","author":"Arterburn","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2017.03.004_bib17","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1093\/jn\/136.8.2236","article-title":"Diet (n-3) polyunsaturated fatty acid content and parity interact to alter maternal rat brain phospholipid fatty acid composition","volume":"136","author":"Levant","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.plefa.2017.03.004_bib18","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1046\/j.1471-4159.2001.00658.x","article-title":"Chronic nutritional deprivation of n-3 alpha-linolenic acid does not affect n-6 arachidonic acid recycling within brain phospholipids of awake rats","volume":"79","author":"Contreras","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.plefa.2017.03.004_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopsych.2010.03.018","article-title":"Review of polyunsaturated fatty acid compositions in patients with depression","volume":"68","author":"Lin","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib20","first-page":"447","article-title":"Fish consumption and depression: the Northern Finland 1966 birth cohort study","volume":"82","author":"Timonen","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.plefa.2017.03.004_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-0327(95)00092-5","article-title":"Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6\/C20:5 omega 3 ratio in cholesteryl esters and phospholipids","volume":"38","author":"Maes","year":"1996","journal-title":"J. Affect. Disord."},{"issue":"Suppl","key":"10.1016\/j.plefa.2017.03.004_bib22","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1007\/BF02637069","article-title":"Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression","volume":"31","author":"Adams","year":"1996","journal-title":"Lipids"},{"key":"10.1016\/j.plefa.2017.03.004_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.biopsych.2004.06.028","article-title":"Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China","volume":"56","author":"Huan","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1176\/ajp.2006.163.6.1100","article-title":"Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk","volume":"163","author":"Sublette","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib25","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/ajcn\/84.6.1308","article-title":"Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials","volume":"84","author":"Appleton","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"1161\u20131163","key":"10.1016\/j.plefa.2017.03.004_bib26","first-page":"1163","article-title":"Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression","volume":"17","author":"Lin","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib27","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4088\/JCP.v67n1217","article-title":"Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry","volume":"67","author":"Freeman","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib28","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4088\/JCP.v68n0712","article-title":"A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids","volume":"68","author":"Lin","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/07315724.2009.10719785","article-title":"EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials","volume":"28","author":"Martins","year":"2009","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.plefa.2017.03.004_bib30","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/mp.2012.25","article-title":"Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis","volume":"17","author":"Martins","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib31","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/mp.2011.100","article-title":"Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis","volume":"17","author":"Bloch","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4088\/JCP.10m06634","article-title":"Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression","volume":"72","author":"Sublette","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3945\/ajcn.2009.28313","article-title":"Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood","volume":"91","author":"Appleton","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2017.03.004_bib34","first-page":"CD004692","article-title":"Omega-3 fatty acids for depression in adults","author":"Appleton","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.plefa.2017.03.004_bib35","doi-asserted-by":"crossref","first-page":"e96905","DOI":"10.1371\/journal.pone.0096905","article-title":"Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials","volume":"9","author":"Grosso","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.plefa.2017.03.004_bib36","first-page":"2055","article-title":"Combined application of eicosapentaenoic acid and docosahexaenoic acid on depression in women: a meta-analysis of double-blind randomized controlled trials","volume":"11","author":"Yang","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.plefa.2017.03.004_bib37","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1038\/tp.2016.29","article-title":"Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder","volume":"6","author":"Mocking","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1476-511X-6-21","article-title":"Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?","volume":"6","author":"Ross","year":"2007","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.plefa.2017.03.004_bib39","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1017\/S1461145714000224","article-title":"Declining efficacy in controlled trials of antidepressants: effects of placebo dropout","volume":"17","author":"Schalkwijk","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.plefa.2017.03.004_bib40","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/00048670701827275","article-title":"Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder","volume":"42","author":"Jazayeri","year":"2008","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/JCP.0b013e31823f3b5f","article-title":"Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder","volume":"32","author":"Gertsik","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.plefa.2017.03.004_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpsychires.2015.12.007","article-title":"Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression","volume":"75","author":"Chhetry","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.plefa.2017.03.004_bib43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","article-title":"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder","volume":"159","author":"Nemets","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib44","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs","volume":"59","author":"Peet","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0924-977X(03)00032-4","article-title":"Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial","volume":"13","author":"Su","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.plefa.2017.03.004_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1176\/appi.ajp.160.1.167","article-title":"Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study","volume":"160","author":"Zanarini","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/bjp.188.1.46","article-title":"Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study","volume":"188","author":"Frangou","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib48","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","article-title":"Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial","volume":"56","author":"Stoll","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib49","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I\/P, Version 2.0)","author":"First","year":"1996"},{"key":"10.1016\/j.plefa.2017.03.004_bib50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jad.2005.03.002","article-title":"Symptom components of standard depression scales and past suicidal behavior","volume":"87","author":"Grunebaum","year":"2005","journal-title":"J. Affect. Disord."},{"issue":"117\u2013123","key":"10.1016\/j.plefa.2017.03.004_bib51","first-page":"e111","article-title":"Validation of a food frequency questionnaire to assess intake of n-3 polyunsaturated fatty acids in subjects with and without major depressive disorder","volume":"111","author":"Sublette","year":"2011","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.plefa.2017.03.004_bib52","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1194\/jlr.D000547","article-title":"High-throughput analysis of fatty acid composition of plasma glycerophospholipids","volume":"51","author":"Glaser","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plefa.2017.03.004_bib53","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ajcn\/80.5.1167","article-title":"Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects","volume":"80","author":"Giltay","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2017.03.004_bib54","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11745-013-3801-7","article-title":"Improvement of major depression is associated with increased erythrocyte DHA","volume":"48","author":"Meyer","year":"2013","journal-title":"Lipids"},{"key":"10.1016\/j.plefa.2017.03.004_bib55","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.euroneuro.2008.04.011","article-title":"A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder","volume":"18","author":"Mischoulon","year":"2008","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.plefa.2017.03.004_bib56","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4088\/JCP.08m04603","article-title":"A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder","volume":"70","author":"Mischoulon","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib57","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.4088\/JCP.14m09660","article-title":"Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements","volume":"77","author":"Carney","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib58","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1176\/ps.2009.60.11.1466","article-title":"The STAR*D trial: revealing the need for better treatments","volume":"60","author":"Insel","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.plefa.2017.03.004_bib59","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S2215-0366(16)30307-8","article-title":"Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies","volume":"3","author":"Furukawa","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.phanu.2014.02.002","article-title":"Detection and treatment of long-chain omega-3 fatty acid deficiency in adolescents with SSRI-resistant major depressive disorder","volume":"2","author":"McNamara","year":"2014","journal-title":"PharmaNutrition"},{"key":"10.1016\/j.plefa.2017.03.004_bib61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3956(03)00077-3","article-title":"A placebo-controlled cross-over trial of adjunctive EPA in OCD","volume":"38","author":"Fux","year":"2004","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.plefa.2017.03.004_bib62","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.4088\/JCP.10m05966blu","article-title":"The efficacy of omega-3 supplementation for major depression: a randomized controlled trial","volume":"72","author":"Lesperance","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.plefa.2017.03.004_bib63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2147\/nedt.1.2.187.61053","article-title":"Possible deleterious effects of adjunctive omega-3 fatty acids in post-traumatic stress disorder patients","volume":"1","author":"Zeev","year":"2005","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.plefa.2017.03.004_bib64","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.euroneuro.2012.08.003","article-title":"Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Mozaffari-Khosravi","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.plefa.2017.03.004_bib65","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1194\/jlr.M900223-JLR200","article-title":"Whole-body synthesis secretion of docosahexaenoic acid from circulating eicosapentaenoic acid in unanesthetized rats","volume":"50","author":"Gao","year":"2009","journal-title":"J. Lipid Res."},{"issue":"Suppl. 2","key":"10.1016\/j.plefa.2017.03.004_bib66","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/j.1740-8709.2011.00319.x","article-title":"Genetic variation in polyunsaturated fatty acid metabolism and its potential relevance for human development and health","volume":"7","author":"Glaser","year":"2011","journal-title":"Maternal & Child Nutrition"},{"key":"10.1016\/j.plefa.2017.03.004_bib67","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12263-014-0437-z","article-title":"Effects of FADS and ELOVL polymorphisms on indexes of desaturase and elongase activities: results from a pre-post fish oil supplementation","volume":"9","author":"Cormier","year":"2014","journal-title":"Genes Nutr."},{"key":"10.1016\/j.plefa.2017.03.004_bib68","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/molbev\/msw049","article-title":"Positive selection on a regulatory insertion-deletion polymorphism in FADS2 influences apparent endogenous synthesis of arachidonic acid","volume":"33","author":"Kothapalli","year":"2016","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.plefa.2017.03.004_bib69","doi-asserted-by":"crossref","first-page":"e17181","DOI":"10.1371\/journal.pone.0017181","article-title":"Genetic variants of the FADS gene cluster and ELOVL gene family, colostrums LC-PUFA levels, breastfeeding, and child cognition","volume":"6","author":"Morales","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.plefa.2017.03.004_bib70","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fneur.2015.00092","article-title":"DNA methylation perturbations in genes involved in polyunsaturated fatty acid biosynthesis associated with depression and suicide risk","volume":"6","author":"Haghighi","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.plefa.2017.03.004_bib71","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.plefa.2013.09.004","article-title":"Kinetics of eicosapentaenoic acid in brain, heart and liver of conscious rats fed a high n-3 PUFA containing diet","volume":"89","author":"Igarashi","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2017.03.004_bib72","article-title":"How polyunsaturated fatty acids modify molecular organization in membranes: insight from NMR studies of model systems","author":"Shaikh","year":"2014","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327816301971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327816301971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T09:36:10Z","timestamp":1542274570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327816301971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":72,"alternative-id":["S0952327816301971"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2017.03.004","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}